JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2003; 41:1056-1062, doi:10.1016/S0735-1097(02)03007-3
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kasahara, H.
Right arrow Articles by Mori, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kasahara, H.
Right arrow Articles by Mori, H.

EXPERIMENTAL STUDY

Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia

Hirofumi Kasahara, MD*, Etsuro Tanaka, MD, PhD{dagger}§, Naoto Fukuyama, MD, PhD{dagger}§, Eriko Sato, MD*, Hiromi Sakamoto, PhD||, Yasuhiko Tabata, PhD, Kiyoshi Ando, MD, PhD{ddagger}§, Harukazu Iseki, MD, PhD{ddagger}, Yoshiro Shinozaki, BS{dagger}, Koji Kimura, MD*, Eriko Kuwabara, MD*, Shirosaku Koide, MD, PhD*, Hiroe Nakazawa, MD, PhD{dagger} and Hidezo Mori, MD, PhD#,*

* Cardiovascular Surgery, Tokai University School of Medicine, Isehara, Japan
{dagger} Physiology, Tokai University School of Medicine, Isehara, Japan
{ddagger} Internal Medicine, Tokai University School of Medicine, Isehara, Japan
§ Research Center for Genetic Engineering and Cell Transplantation, Tokai University School of Medicine, Isehara, Japan
|| Genetics Division, National Cancer Center Research Institute, Tokyo, Japan
Research Center for Biomedical Engineering, Kyoto University, Kyoto, Japan
# Department of Cardiac Physiology, National Cardiovascular Center Research Institute, Suita, Japan

Manuscript received December 30, 2001; revised manuscript received July 2, 2002, accepted November 5, 2002.

* Reprint requests and correspondence: Dr. Hidezo Mori, Department of Cardiac Physiology, National Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita 565-8565, Japan.
hidemori{at}ri.ncvc.go.jp

OBJECTIVES: We investigated the potentiation of gene therapy using fibroblast growth factor 4 (FGF4)-gene by combining plasmid deoxyribonucleic acid (DNA) with biodegradable gelatin hydrogel (GHG).

BACKGROUND: Virus vectors transfer genes efficiently but are biohazardous, whereas naked DNA is safer but less efficient. Deoxyribonucleic acid charges negatively; GHG has a positively charged structure and is biodegradable and implantable; FGF4 has an angiogenic ability.

METHODS: The GHG-DNA complex was injected into the hindlimb muscle (63 mice and 55 rabbits). Gene degradation was evaluated by using 125I-labeled GHG-DNA complex in mice. Transfection efficiency was evaluated with reverse-transcription nested polymerase chain reaction and X-Gal histostaining. The therapeutic effects of GHG-FGF4-gene complex (GHG-FGF4) were evaluated in rabbits with hindlimb ischemia.

RESULTS: Gelatin hydrogel maintained plasmid in its structure, extending gene degradation temporally until 28 days after intramuscular delivery, and improving transfection efficiency. Four weeks after gene transfer, hindlimb muscle necrosis was ameliorated more markedly in the GHG-FGF4 group than in the naked FGF4-gene and GHG-beta-galactosidase (control) groups (p < 0.05, Kruskal-Wallis test). Synchrotron radiation microangiography (spatial resolution, 20 µm) and flow determination with microspheres confirmed significant vascular responsiveness to adenosine administration in the GHG-FGF4 group, but not in the naked FGF4-gene and the control.

CONCLUSIONS: The GHG-FGF4 complex promoted angiogenesis and blood flow regulation of the newly developed vessels possibly by extending gene degradation and improving transfection efficiency without the biohazard associated with viral vectors.

Abbreviations and Acronyms
  ANOVA
  analysis of variance
  cDNA
  complementary deoxyribonucleic acid
  DNA
  deoxyribonucleic acid
  FGF4
  fibroblast growth factor 4
  GHG
  gelatin hydrogel
  lacZ
  beta-galactosidase
  NIH
  National Institute of Health
  PBS
  phosphate-buffered saline
  pI
  isoelectric point
  RNA
  ribonucleic acid
  RT-nested PCR
  reverse transcription-nested polymerase chain reaction




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. Nagaya, H. Mori, S. Murakami, K. Kangawa, and S. Kitamura
Adrenomedullin: angiogenesis and gene therapy
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1432 - R1437.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.